Hong Kong stocks fluctuate | Lai Kai Medicine-B (02105.HK) rises more than 4% in the afternoon, lowering fat and increasing muscle is the next generation of GLP-1 competition focus. LAE102 attracts market attention.

According to the Oriental Fortune financial app, Lai Kai Pharmaceuticals-B (02105.HK) rose more than 4% in the afternoon, rising 3.33% to 14.26 Hong Kong dollars as of the time of publication, with a turnover of 14.8717 million Hong Kong dollars.